Home
University & Research Institutions

Sector: University & Research Institutions

How a DNA sequencing start-up proved it is no pushover

TwinStrand co-founder’s grandfather famously didn’t patent the polio vaccine, but Dr Jesse Salk believes that protecting inventions is key to getting products to reach the market

Historic CRISPR drug approval heralds new era in Cas9 IP wars

Green light for first ever Cas9 therapy ushers in next phase of licensing and litigation efforts.

CRISPR-Cas9 drugmakers like Vertex should come to the table early, says ToolGen’s IP chief

Chief Legal Officer Yoori Kim argues that current patent uncertainty should fuel rather than thwart licensing deals

Latest content

WHO’s vaccine successes show significance of Moderna covid IP pledge

African tech transfer hub is making fast progress in replicating the approved mRNA jab

18 January 2022

Australia under-invests in IP, and recent government proposals will not fix that

Saturday Opinion: In-house leaders say a mooted patent box regime limited to life sciences will reward companies that get patents already, failing to encourage IP investment in new industries

04 December 2021

Data monetisation drives Sanofi’s $180 million investment in AI biotech Owkin

The deal shows how privacy and silo barriers to the commercialisation of information are being overcome

29 November 2021

Nobel laureate’s troubles are a cautionary tale about the importance of university tech-transfer support

Tasuku Honjo’s recent patent battles highlight the potential IP dangers of academic collaborations

18 November 2021

Patent suits decline in Dusseldorf and Mannheim, but Munich’s docket is on the rise

Germany is Europe’s biggest and most active litigation forum, but subtle differences in case law and proceedings mean that plaintiffs have important choices to make about where to file their suits

16 November 2021

Xperi highlights recent China deal as it seeks to "re-establish" its chip licensing business

Licence pact with Yangtze Memory heralds new applications for a technology that’s core to the company’s semiconductor holdings

15 November 2021

A multi-million-dollar patent damages win for J&J in China is good news for foreign rights holders

US company’s subsidiary secures major award against a local infringer at the Supreme People’s Court

12 November 2021

Moderna on IP collision course with US government

The company is at loggerheads with National Institutes of Health over inventorship of crucial covid vaccine technology

11 November 2021

IP rights are an important part of the push for more renewables

Saturday Opinion: IP protection is a significant driver of clean energy production, but it’s not the only key factor

06 November 2021

A $650 million deal is the latest in a growing number of CRISPR IP transactions

Last week’s licensing agreement between Mammoth and Vertex shows how deal-making in the space is gathering momentum

05 November 2021

Unlock unlimited access to all IAM content